about
Targeted exercise therapy for voice and swallow in persons with Parkinson's diseaseSpeech and Swallowing in Parkinson's Disease.Differential contributions of basal ganglia and thalamus to song initiation, tempo, and structure.Relationships among rat ultrasonic vocalizations, behavioral measures of striatal dopamine loss, and striatal tyrosine hydroxylase immunoreactivity at acute and chronic time points following unilateral 6-hydroxydopamine-induced dopamine depletion.Vocal training, levodopa, and environment effects on ultrasonic vocalizations in a rat neurotoxin model of Parkinson disease.Listener Perception of Monopitch, Naturalness, and Intelligibility for Speakers With Parkinson's Disease.Early identification and treatment of communication and swallowing deficits in Parkinson disease.Treatment of dysarthria following subthalamic nucleus deep brain stimulation for Parkinson's disease.Effects of loudness cues on respiration in individuals with Parkinson's disease.A cognitive-perceptual approach to conceptualizing speech intelligibility deficits and remediation practice in hypokinetic dysarthriaSubthalamic nucleus deep brain stimulation changes velopharyngeal control in Parkinson's disease.Subthalamic nucleus deep brain stimulation changes speech respiratory and laryngeal control in Parkinson's diseaseLimb use and complex ultrasonic vocalization in a rat model of Parkinson's disease: deficit-targeted training.Qualitative changes in ultrasonic vocalization in rats after unilateral dopamine depletion or haloperidol: a preliminary study.
P2860
Q22252333-A8E74FD6-6723-4596-BAB5-13264A7B945FQ24649365-A8D83B65-A134-48D8-8A2E-717468A97B7FQ28659215-B60E4990-70E9-493F-9EF0-A2D40E6E764BQ30374427-BE120334-0588-452D-870F-C55C48FDF879Q30380046-0809B4AE-FF31-4516-AB4C-15E235171CC2Q30390464-13DE0D12-1814-4FD0-BE2A-8324FFE3A813Q30408790-49BC2023-D97F-4601-8848-65C06131FEEAQ30461934-748630B0-F00D-4E24-8A70-55A7652F7EA1Q30463629-9E33F78B-E598-4C70-A596-FDF928B8DBCCQ30474147-60A913CE-20F3-4D90-8761-8DA921896F50Q30476711-E22CD556-91BC-4D8D-94A0-609085A817A3Q30477330-DB41D292-1CF3-458A-99A9-B8E613E13A2BQ30487022-A2F889F3-D0B4-47C2-909D-8775B67B43F6Q30493550-CE8F98DB-E569-4A4E-A64B-B51D632993FB
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Speech treatment for Parkinson's disease.
@ast
Speech treatment for Parkinson's disease.
@en
type
label
Speech treatment for Parkinson's disease.
@ast
Speech treatment for Parkinson's disease.
@en
prefLabel
Speech treatment for Parkinson's disease.
@ast
Speech treatment for Parkinson's disease.
@en
P2093
P1433
P1476
Speech treatment for Parkinson's disease
@en
P2093
Cynthia Fox
Eugene C Lai
Julia Howard
Lorraine Olson Ramig
Marilyn Trail
Shimon Sapir
P304
P577
2005-01-01T00:00:00Z